Patent Portfolio

The following table summarizes the key U.S. Patent estate of Biomoda.  Patent protection in numerous foreign countries, based on these domestic patents, is in place or pending.

U.S. Patent Title

  • 6,838,248 – Compositions and Methods for Detecting Pre-Cancerous Conditions in Cell and Tissue Samples Using 5, 10, 15, 20-Tetrakis (Carboxyphenyl) Porphine
  • 7,384,764 – Method for Prognosing Response to Cancer Therapy with 5, 10, 15, 20-Tetrakis (Carboxyphenyl) Porphine
  • 7,670,799 – Compositions and Methods of Making 5, 10, 15, 20-Tetrakis (Carboxyphenyl) Porphine
  • 61/226,646-  System and Method for Analyzing Samples Labeled with 5, 10, 15, 20-Tetrakis (4-Carboxyphenyl) Porphine(TCPP) (Pending)

The following chart shows the current patents and their relationship to each other.

Biomoda, Inc.

Meso Tetra (4-Carboxyphenyl) Porphine (TCPP) is a porphyrin, one of a group of organic compounds, many of which occur in nature but which can also be synthesized in a laboratory.  From a Greek word for “purple,” porphyrins are found in the cells of both animals and plants, where they perform a wide variety of functions. Porphyrin molecules bind with metals and have an affinity for neoplastic tissue, traits that allow TCPP to easily embed in cancer cells.

Useful Links

Site Map Contact Us